Rare diseases
Investigational molecules
Locations
Mijlenmeersstraat 90, 1070 Anderlecht, Belgium
Clinical activity includes early breast cancer, luminal B breast cancer, HER2-positive breast carcinoma, and triple-negative breast cancer, with attention to treatment selection, tumour profiling, and surgical planning.
Research also covers imaging-guided decision-making, intraoperative assessment, and systemic treatment approaches in both hormone receptor-positive and aggressive breast cancer subtypes.
Institut Jules Bordet runs clinical trials in conditions such as Breast cancer metastatic, Hormone receptor positive breast cancer, Rectal cancer stage III, Rectal cancer stage II, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
